Table IV.
Predictive distributions*obtained for the between-study heterogeneity 
in a future meta-analysis, across 80 different settings.
| Outcome type | Intervention comparison type |
||||
|---|---|---|---|---|---|
| Pharmacological vs. | Pharmacological vs. | Non-pharmacological†vs. | Non-pharmacological†vs. | Non-pharma.†vs. | |
| Placebo/control | Pharmacological | Placebo/control | Pharmacological | Non-pharma.† | |
| All-cause mortality | LN(−3.95,1.342) | LN(−4.18,1.412) | LN(−4.17,1.552) | LN(−2.92,1.022) | LN(−3.50,1.262) |
| Obstetric outcomes | LN(−3.52,1.742) | LN(−3.75,1.792) | LN(−3.74,1.912) | LN(−2.49,1.502) | LN(−3.08,1.682) |
| Cause-specific mortality/major | LN(−3.71,1.742) | LN(−3.95,1.792) | LN(−3.93,1.912) | LN(−2.68,1.512) | LN(−3.27,1.682) |
| morbidity event/composite | |||||
| (mortality or morbidity) | |||||
| Resource use/hospital stay/process | LN(−2.34,1.742) | LN(−2.58,1.792) | LN(−2.56,1.912) | LN(−1.31,1.502) | LN(−1.90,1.682) |
| Surgical/device related | LN(−2.14,1.742) | LN(−2.37,1.792) | LN(−2.36,1.912) | LN(−1.11,1.502) | LN(−1.69,1.682) |
| success/failure | |||||
| Withdrawals/drop-outs | LN(−2.99,1.742) | LN(−3.23,1.792) | LN(−3.21,1.912) | LN(−1.96,1.512) | LN(−2.55,1.682) |
| Internal/external structure-related | LN(−2.71,1.742) | LN(−2.94,1.792) | LN(−2.93,1.922) | LN(−1.67,1.512) | LN(−2.26,1.682) |
| outcomes | |||||
| General physical health indicators | LN(−2.29,1.532) | LN(−2.53,1.582) | LN(−2.51,1.722) | LN(−1.26,1.252) | LN(−1.85,1.462) |
| Adverse events | LN(−1.87,1.522) | LN(−2.10,1.582) | LN(−2.10,1.712) | LN(−0.84,1.242) | LN(−1.43,1.452) |
| Infection/onset of new disease | LN(−2.49,1.522) | LN(−2.73,1.582) | LN(−2.71,1.712) | LN(−1.46,1.242) | LN(−2.05,1.452) |
| Signs/symptoms reflecting | LN(−2.06,1.512) | LN(−2.29,1.582) | LN(−2.28,1.712) | LN(−1.03,1.242) | LN(−1.61,1.452) |
| continuation/end of condition | |||||
| Pain | LN(−1.83,1.522) | LN(−2.06,1.582) | LN(−2.05,1.712) | LN(−0.80,1.252) | LN(−1.38,1.452) |
| Quality of life/functioning | LN(−2.54,1.542) | LN(−2.78,1.602) | LN(−2.77,1.732) | LN(−1.51,1.272) | LN(−2.10,1.472) |
| (dichotomised) | |||||
| Mental health indicators | LN(−2.12,1.532) | LN(−2.35,1.602) | LN(−2.34,1.722) | LN(−1.09,1.272) | LN(−1.67,1.472) |
| Biological markers | LN(−1.77,1.522) | LN(−2.00,1.582) | LN(−1.99,1.712) | LN(−0.74,1.242) | LN(−1.33,1.452) |
| (dichotomised) | |||||
| Subjective outcomes (various)† | LN(−2.70,1.522) | LN(−2.93,1.582) | LN(−2.92,1.712) | LN(−1.67,1.252) | LN(−2.26,1.452) |
*
Fitted distributions reported as log-normal(μ,σ2), where μand σare the mean and standard deviation on the log scale.
*
†Subjective outcomes (various) and non-pharmacological interventions defined in Table IV.